Patents by Inventor Paul Michael Murray

Paul Michael Murray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120289520
    Abstract: DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro-drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, obesity
    Type: Application
    Filed: April 25, 2012
    Publication date: November 15, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Alan Martin Birch, Roger John Butlin, Leonie Campbell, Clive Green, Andrew Leach, Michael James Waring, Paul Michael Murray, Per Olof Ryberg
  • Patent number: 8188092
    Abstract: DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro-drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, obesity wherein, for example, r is 0 or 1 and X1 is linear (1-3C)alkyl; q is 0 or 1 and X2 is fluoro, chloro or (1-3C)alkyl; Y1 is selected from fluoro, chloro, bromo, cyano, (1-3C)alkyl and (1-2C)alkoxy; n is 0, 1 or 2 and Y2 is fluoro, chloro or (1-3C)alkyl; p is 0, 1 or 2 and Y3 is (1-3C)alkyl or forms a (3-5C)cycloalkyl ring; Z is carboxy or —CONHSO2Me or —CONRbRc wherein Rb and Rc are independently selected, for example, from hydrogen and (1-4C)alkyl or Rb and Rc are linked so as to form a morpholine ring or a (4-6C)heterocyclic ring and when Z is —CONRbRc the Rb and Rc groups may be optionally substituted by carboxy.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: May 29, 2012
    Assignee: AstraZeneca AB
    Inventors: Alan Martin Birch, Roger John Butlin, Leonie Campbell, Clive Green, Andrew Leach, Michael James Waring, Paul Michael Murray, Per Olof Ryberg
  • Patent number: 8034932
    Abstract: A process for formation of a compound of formula (I) or a pharmaceutically acceptable salt thereof, (A chemical formula should be inserted here—please see paper copy enclosed herewith) I via a Heck reaction is described. Intermediates useful in the process and processes for making said intermediates are also described.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: October 11, 2011
    Assignee: AstraZeneca UK Limited
    Inventors: Michael Butters, Steven Robert Lenger, Paul Michael Murray, Evan William Snape
  • Publication number: 20100324068
    Abstract: DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro-drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, obesity wherein, for example, r is 0 or 1 and X1 is linear (1-3C)alkyl; q is 0 or 1 and X2 is fluoro, chloro or (1-3C)alkyl; Y1 is selected from fluoro, chloro, bromo, cyano, (1-3C)alkyl and (1-2C)alkoxy; n is 0, 1 or 2 and Y2 is fluoro, chloro or (1-3C)alkyl; p is 0, 1 or 2 and Y3 is (1-3C)alkyl or forms a (3-5C)cycloalkyl ring; Z is carboxy or —CONHSO2Me or —CONRbRc wherein Rb and Rc are independently selected, for example, from hydrogen and (1-4C)alkyl or Rb and Rc are linked so as to form a morpholine ring or a (4-6C)heterocyclic ring and when Z is —CONRbRc the Rb and Rc groups may be optionally substituted by carboxy.
    Type: Application
    Filed: June 18, 2010
    Publication date: December 23, 2010
    Applicant: AstraZeneca AB
    Inventors: Alan Martin Birch, Roger John Butlin, Leonie Campbell, Clive Green, Andrew Leach, Michael James Waring, Paul Michael Murray, Per Olof Ryberg
  • Patent number: 7671195
    Abstract: A dibenzothiazepine compound is suitably prepared by subjecting a 2-amino-2?-carboxy-diphenylsulfide compound to dehydration-condensation reaction in the presence of an acidic catalyst; the 2-amino-2?-carboxy-diphenylsulfide compound is suitably prepared by reducing a 2-nitro-2?-carboxy-diphenylsulfide compound in a lower aliphatic ester solvent; and the 2-nitro-2?-carboxy-diphenylsulfide compound is suitably prepared by reacting a nitrobenzene compound with a thiosalicylic acid compound in a mixture of a lower aliphatic alcohol and water.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: March 2, 2010
    Assignees: AstraZeneca UK Limited, UBE Industries, Ltd.
    Inventors: Paul Michael Murray, Luis-Manuel Vaz, Debra Ainge, Katsumasa Harada, Shigeyoshi Nishino, Kiyotaka Yoshii
  • Publication number: 20080207903
    Abstract: A process for formation of a compound of formula (I) or a pharmaceutically acceptable salt thereof, (A chemical formula should be inserted here—please see paper copy enclosed herewith) I via a Heck reaction is described. Intermediates useful in the process and processes for making said intermediates are also described.
    Type: Application
    Filed: December 22, 2005
    Publication date: August 28, 2008
    Inventors: Michael Butters, Steven Robert Lenger, Paul Michael Murray, Evan William Snape
  • Patent number: 4119956
    Abstract: A raster-scan display system for computer-generated images in which each raster line is quantized into a number (N) of sets of image elements each successive set being displaced in time, with respect to the line start, by 1/N of the duration of one element. The corresponding video signals are summed for each line and the resultant signal is displayed. The technique provides a visual image with graded intensity changes more nearly simulating a television type image, instead of a stepwise changing image. In one form of the invention, a triangular hold technique is used, that is, the display is delayed to permit of a linearly changing intensity charge between consecutive elements of different intensity.
    Type: Grant
    Filed: June 22, 1976
    Date of Patent: October 10, 1978
    Assignee: Redifon Flight Simulation Limited
    Inventor: Paul Michael Murray
  • Patent number: 4056827
    Abstract: An optical display system for a craft navigation simulator providing a wide angle display of greater than 3:1 width/height format derived from a closed circuit television camera viewing a terrain model. A wide-angle scene viewed is divided into three or more parts at vertical boundaries all of which are off-center and folded by a first optical system into substantially square format, in which format the composite image is processed from camera tube to display tube. A second optical system reconstructs the original wide angle image. By this means, high definition of the image in the center region and, particularly, near the horizon, is maintained.
    Type: Grant
    Filed: October 28, 1975
    Date of Patent: November 1, 1977
    Assignee: Redifon Limited
    Inventors: Archer Michael Spooner, Paul Michael Murray